Translation and Adaptation of the STOPP/START Criteria Version 3 for Potentially Inappropriate Prescribing in Older People to European Portuguese: A Study Protocol
DOI:
https://doi.org/10.20344/amp.21941Keywords:
Aged, Drug Prescriptions, Inappropriate Prescribing, Portugal, Potentially Inappropriate Medication List, Practice Patterns, PhysiciansAbstract
Introduction: As the global population ages, managing medication use in older adults becomes increasingly complex due to polypharmacy and the associated risks of adverse drug events. To improve the safety and appropriateness of medication use in the older population, tools like the Screening Tool of Older Persons’ Prescriptions (STOPP) and Screening Tool to Alert doctors to Right Treatment (START) criteria have been developed. The availability of updated criteria is crucial to better support healthcare professionals in Portuguese-speaking regions. The aim of this study is to translate and validate the STOPP/START version 3 criteria for Portuguese, providing an updated and useful tool for healthcare professionals.
Methods and Analysis: This study will be conducted through four phases: I) translation of the STOPP/START version 3 criteria to European Portuguese; II) collection of sociodemographic, clinical, and medication data; III) intrarater reliability study; and IV) interrater agreement study. This study obtained ethics approval by the Ethics Committee of the Administração Regional de Saúde do Centro, Portugal. The availability of the translated criteria will enable the integration of STOPP/START version 3 into clinical practice in Portugal, facilitating improved medication safety and appropriateness. This integration is expected to lead to better management of polypharmacy and a reduction in adverse drug events, ultimately enhancing patient outcomes and supporting evidence-based prescribing practices.
Downloads
References
United Nations. World population prospects 2022. 2022. [cited 2024 Apr 15]. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf.
Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6-11. DOI: https://doi.org/10.1016/j.maturitas.2020.05.018
Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health. 2018;15:310. DOI: https://doi.org/10.3390/ijerph15020310
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. DOI: https://doi.org/10.1186/s12877-017-0621-2
Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71:1415-27. DOI: https://doi.org/10.1007/s00228-015-1954-4
Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VM. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74:679-700. DOI: https://doi.org/10.1007/s00228-018-2446-0
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-32. DOI: https://doi.org/10.1001/archinte.151.9.1825
Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau CE, et al. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-31. DOI: https://doi.org/10.1111/j.1532-5415.2012.03923.x
Samuel MJ. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227-46. DOI: https://doi.org/10.1111/jgs.13702
Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674-94. DOI: https://doi.org/10.1111/jgs.15767
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052-81. DOI: https://doi.org/10.1111/jgs.18372
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72-83. DOI: https://doi.org/10.5414/CPP46072
O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing. 2015;44:213-8. DOI: https://doi.org/10.1093/ageing/afu145
O’Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14:625-32. DOI: https://doi.org/10.1007/s41999-023-00777-y
Aguiar JP, Gama Marques J, Alves da Costa F. Utility and limitations of a screening tool of older person’s prescription among psychiatric elder patients: a comprehensive review. Aging Health Res. 2021;1:100031. DOI: https://doi.org/10.1016/j.ahr.2021.100031
Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:e2326910. DOI: https://doi.org/10.1001/jamanetworkopen.2023.26910
De Oliveira Martins S, Soares MA, Foppe Van Mil JW, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients - effect of the beers criteria update. Pharmacy World and Science. 2006;28:296-301. DOI: https://doi.org/10.1007/s11096-006-9046-2
Eiras A, Teixeira MA, González-Montalvo JI, Castell MV, Queipo R, Otero Á. Consumption of drugs in over 65 in Porto (Portugal) and risk of potentially inappropriate medication prescribing. Aten Primaria. 2016;48:110-20. DOI: https://doi.org/10.1016/j.aprim.2015.03.005
Simões PA, Santiago LM, Maurício K, Simões JA. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: a nationwide cross-sectional study. Patient Prefer Adherence. 2019;13:1569-76. DOI: https://doi.org/10.2147/PPA.S219346
Monteiro C, Canário C, Ribeiro MÂ, Duarte AP, Alves G. Medication evaluation in Portuguese elderly patients according to beers, stopp/start criteria and EU(7)-PIM list – an exploratory study. Patient Prefer Adherence. 2020;14:795-802. DOI: https://doi.org/10.2147/PPA.S247013
da Costa FA, Periquito C, Carneiro MC, Oliveira P, Fernandes AI, Cavaco-Silva P. Potentially inappropriate medications in a sample of Portuguese nursing home residents: does the choice of screening tools matter? Int J Clin Pharm. 2016;38:1103-11. DOI: https://doi.org/10.1007/s11096-016-0337-y
Peixoto S, Almeida A, Caramelo A, Mendes L. Application of the 2015 beers criteria operationalized for portugal in institutionalized elderly: a crosssectional study. Acta Med Port. 2020;33:741-8. DOI: https://doi.org/10.20344/amp.13030
Aguiar JP, Costa LH, da Costa FA, Leufkens HG, Martins AP. Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities. Clin Interv Aging. 2019;14:535-47. DOI: https://doi.org/10.2147/CIA.S192252
AL-Musawe L, Torre C, Guerreiro JP, Rodrigues AT, Raposo JF, Mota-Filipe H, et al. Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life. Pharmacol Res Perspect. 2020;8:e00621. DOI: https://doi.org/10.1002/prp2.621
Perpétuo C, Plácido AI, Rodrigues D, Aperta J, Piñeiro-Lamas M, Figueiras A, et al. Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: concordance and overlap among the EU(7)-PIM list and beers and STOPP Criteria. Front Pharmacol. 2021;12:676020. DOI: https://doi.org/10.3389/fphar.2021.676020
Candeias C, Gama J, Rodrigues M, Falcão A, Alves G. Potentially inappropriate medications and potential prescribing omissions in elderly patients receiving post-acute and long-term care: application of screening tool of older people’s prescriptions/screening tool to alert to right treatment criteria. Front Pharmacol. 2021;12:747523. DOI: https://doi.org/10.3389/fphar.2021.747523
Plácido AI, Aguiar A, Piñeiro-Lamas M, Varallo F, Figueiras A, Herdeiro MT, et al. Assessment of potentially inappropriate medications using the EU (7)-PIM List, in a sample of portuguese older adults’ residents in nursing homes. Risk Manag Healthc Policy. 2022;15:1343-52. DOI: https://doi.org/10.2147/RMHP.S346300
Monteiro L, Monteiro-Soares M, Matos C, Ribeiro-Vaz I, Teixeira A, Martins C. inappropriate prescriptions in older people—translation and adaptation to portuguese of the STOPP/START Screening Tool. Int J Environ Res Public Health. 2022;19:6896. DOI: https://doi.org/10.3390/ijerph19116896
Dalleur O, Pharm M, Lang PO, Boland B. La nouvelle version des critères STOPP/START adaptée en français. Pharmactuel. 2016;49:61-4.
Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, García MM, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M, et al. Spanish version of the STOPP/START 3 criteria: Advances in the detection of inappropriate prescribing medication in the older people. Rev Esp Geriatr Gerontol. 2023;58:101407. DOI: https://doi.org/10.1016/j.regg.2023.101407
Vermeulen Windsant-van den Tweel AM, Verduijn MM, Derijks HJJ, van Marum RJ. Detectie van ongeschikt medicatiegebruik bij ouderen; worden de STOPP-en START-criteria de nieuwe standaard? Ned Tijdschr Geneeskd. 2012;156:A5076.
Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, et al. Screening tool for older persons’ appropriate prescriptions in japanese: report of the Japan Geriatrics Society Working Group on “guidelines for medical treatment and its safety in the elderly.” Geriatr Gerontol Int. 2016;16:983-1001. DOI: https://doi.org/10.1111/ggi.12890
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94-104. DOI: https://doi.org/10.1111/j.1524-4733.2005.04054.x
Streiner DL, Norman GR. Biases in responding. In: Health Measurement Scales. Oxford: Oxford University Press; 2009. DOI: https://doi.org/10.1093/acprof:oso/9780199231881.001.0001
Shoukri MM. Measures of interobserver agreement and reliability. Boca Raton: CRC Press; 2010. DOI: https://doi.org/10.1201/b10433
Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, et al. Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. Int J Nurs Stud. 2011;48:661-71. DOI: https://doi.org/10.1016/j.ijnurstu.2011.01.016
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74. DOI: https://doi.org/10.2307/2529310
Laatikainen O, Sneck S, Turpeinen M. Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge. Eur J Clin Pharmacol. 2022;78:159-70. DOI: https://doi.org/10.1007/s00228-021-03213-x
Falemban AH. Medication-related problems and their intervention in the geriatric population: a review of the literature. Cureus. 2023:e44594. DOI: https://doi.org/10.7759/cureus.44594
Direção-Geral da Saúde. Norma N.o 018/2016 reconciliação da medicação. 2016. [cited 2024 Aug 07]. Available from: https://normas.dgs.min-saude.pt/wp-content/uploads/2019/10/reconciliacao-da-medicacao.pdf.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
